Takeda Pharmaceutical (4502.T) Debt Metrics

Price: $4543
Market Cap: $7.20T
Avg Volume: 4.12M
Country: JP
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Beta: 0.414
52W Range: $3852-4573
Website: Takeda Pharmaceutical

How much debt does Takeda Pharmaceutical have?

According to Takeda Pharmaceutical's latest annual financial reports, the company's debt profile is as follows:

Total Debt and Liabilities

Takeda Pharmaceutical's total debt stands at $4.84T. This is broken down into:

  • Long-term debt: $5.03T
  • Short-term debt: $367.25B

The company's net debt, which accounts for cash and cash equivalents, is $4.39T. In terms of overall financial obligations, Takeda Pharmaceutical's total liabilities amount to $7.83T.

Debt Ratios and Metrics

To better understand Takeda Pharmaceutical's debt position, we can look at several key ratios:

  • Debt to Equity Ratio: 0.67 - this indicates the proportion of equity and debt the company uses to finance its assets.
  • Debt Ratio: 32.06% - this shows the proportion of a company's assets that are financed through debt.
  • Interest Coverage Ratio: 1.39 - this measures how easily a company can pay interest on its outstanding debt.
  • Long-term Debt to Capitalization: 38.10% - this shows the proportion of long-term debt in the company's capital structure.
  • Total Debt to Capitalization: 39.97% - this indicates the total debt in the company's capital structure.

These metrics provide insight into Takeda Pharmaceutical's financial leverage and its ability to meet financial obligations. For a comprehensive understanding of the company's financial health, it's important to consider these debt metrics alongside other financial indicators and industry benchmarks.

Total Debt

$4.84T

Long-term Debt

$5.03T

Short-term Debt

$367.25B

Net Debt

$4.39T

Total Liabilities

$7.83T

Interest Coverage

1.39

Debt to Equity Ratio

0.67

Debt Ratio

32.06%

Takeda Pharmaceutical Historical Debt Metrics
Total Debt
Long-term Debt
Short-term Debt
Net Debt
$8.00T$8.00T$6.00T$6.00T$4.00T$4.00T$2.00T$2.00T$0.00$0.00Debt Metrics201620162017201720182018201920192020202020212021202220222023202320242024

Takeda Pharmaceutical Historical Debt

The table below shows various debt metrics for each year, with the latest data available for the last fiscal year 2023.

Year Total Debt Long-term Debt Short-term Debt Net Debt Total Liabilities Debt to Equity Debt Ratio Interest Coverage Long-term Debt to Capitalization Total Debt to Capitalization
2023 $4.84T $5.03T $367.25B $4.39T $7.83T 0.67 32.06% 1.39 38.10% 39.97%
2022 $4.38T $4.46T $399.22B $3.85T $7.60T 0.69 31.40% 2.89 38.88% 40.82%
2021 $4.35T $4.55T $257.87B $3.50T $7.49T 0.76 32.97% 2.77 42.15% 43.33%
2020 $4.64T $5.00T $72.34B $3.67T $7.74T 0.90 35.90% 2.05 47.14% 47.26%
2019 $5.09T $4.83T $627.90B $4.46T $8.09T 1.08 39.73% 0.61 48.82% 51.88%
2018 $5.75T $4.94T $987.09B $5.05T $8.71T 1.11 41.46% 4.26 48.02% 52.71%
2017 $985.66B $1.04T $2.15B $691.14B $2.09T 0.49 24.00% 7.57 33.04% 33.04%
2016 $1.14T $656.56B $547.14B $825.43B $2.41T 0.60 26.28% 6.70 24.05% 37.67%
2015 $768.22B $590.38B $231.82B $316.80B $1.81T 0.39 20.09% 4.10 21.69% 28.28%
2014 $729.38B $645.57B $103.25B $77.23B $2.09T 0.34 16.98% -3.93 22.75% 25.45%

Related Metrics

Explore detailed financial metrics and analysis for 4502.T.